Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Introductory guidance on choosing long-term holds for beginners, focusing on fundamentals, liquidity, and project viability.
27,784 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Early investors rode a 135% rally after D-Wave’s 2022 SPAC debut, but the current wave of buyers faces a tougher, mor...
Kraft Heinz trimmed guidance after a challenging quarter, McCormick posted steady growth with margin pressure, and Ho...
Investors eye Iran talks as a key driver of energy prices and risk. A tentative memo leaves room for a final deal, bu...
Meta Platforms is ending Horizon Worlds as a standalone VR social platform and redirecting capital to AI infrastructu...
Oracle just posted its strongest quarter ever with massive cloud backlog, yet investors face a capital-heavy path ahe...
A bold government push is reshaping quantum tech and investing. Learn which three big stocks are positioned to win, a...
As market conditions shift in early 2026, those earning $400K face tougher retirement math. This report outlines the ...
The Baupost founder made a bold, selective move: trim a large Alphabet stake and pivot to a fintech name that slumped...
Berkshire Hathaway names Greg Abel as CEO, with Buffett signaling strong confidence as the company holds a cash-heavy...
A tiny stock in the nuclear space could offer outsized gains if key milestones hit. Learn how to evaluate the opportu...
When artists leave the major label system, money and control shift too. This article breaks down how Bebe Rexha’s Dir...